<html>

<head>
    <link href="./static/vendor/bootstrap/css/bootstrap.css" rel="stylesheet">
    <link href="./static/css/outliers.css" rel="stylesheet">
    <meta charset="UTF-8">
</head>

<body>
    <div class="container">
        <h1>Static outliers for Colte Partnership (Tmr) PCN</h1>
        <p>There is substantial variation in prescribing behaviours, across various different areas of medicine. Some variation can be explained by demographic changes, or local policies or guidelines, but much of the remaining variation is less easy to
            explain. At <a href="https://openprescribing.net/">OpenPrescribing</a> we are piloting a number of data-driven approaches to: identify unusual prescribing, collect feedback on this prescribing to inform development of new tools to support
            prescribers and organisations to audit and review prescribing.</p>
        <p>The below reports have been developed to use “z-scores” to automatically identify prescribing patterns at a chemical level which are furthest away from “typical prescribing” and can be classified as an “outlier”. It is important to remember that
            this information was generated automatically and it is therefore likely that some of the behaviour is warranted. This report seeks only to collect information about where this variation may be warranted and where it might not. Our full analytical
            method code is openly available on GitHub <a href="https://github.com/ebmdatalab/outliers/">here</a> but briefly we calculate the number of prescriptions for each chemical in the BNF coding system using the BNF subparagraph as a denominator.
            We used the time period from 1 April 2021 to 1 August 2021. We then calculate the mean and standard deviation for each numerator and denominator pair across all practices/CCGs/PCNs. From this we can calculate the “z-score”, which is a measure
            of how many standard deviations a given practice/CCG/PCN is from the population mean. We then rank your “z-scores” to find the top 5 results where prescribing is an outlier for prescribing higher than its peers and those where it is an outlier
            for prescribing lower than its peers.</p>
        <p>The DataLab is keen to hear your feedback on the results. You can do this by completing the following <a href="https://docs.google.com/forms/d/e/1FAIpQLSeH4ai_qyetAY4UAgZSWGnYQHkXNr9efFBmQvdrBi5uuXvgnQ/viewform?usp=pp_url&entry.2016356131=+">survey</a>            or emailing us at
            <a href="mailto:ebmdatalab@phc.ox.ac.uk?subject=OpenPrescribing%20outliers%20feedback">ebmdatalab@phc.ox.ac.uk</a>. Please DO NOT INCLUDE IDENTIFIABLE PATIENT information in your feedback. All feedback is helpful, you can send short or detailed
            feedback.
        </p>
        <h2>Prescribing where Colte Partnership (Tmr) PCN is higher than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_high">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U72457&amp;numIds=120303000&amp;denomIds=12.3.3&amp;selectedTab=summary">Other lozenge and spray preparations</a><button type="button" data-toggle="collapse" data-target="#table_high_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>1</td>
      <td>Lozenges and sprays</td>
      <td>1</td>
      <td>1.00</td>
      <td>0.01</td>
      <td>0.08</td>
      <td>12.86</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U72457&amp;numIds=120303000BBBYAI&amp;denomIds=12.3.3&amp;selectedTab=summary" target="_blank">Buttercup Bronchostop Cough pastilles : 1</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U72457&amp;numIds=0904010Z0&amp;denomIds=9.4.1&amp;selectedTab=summary">Gluten free/low protein biscuits</a><button type="button" data-toggle="collapse" data-target="#table_high_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>16</td>
      <td>Foods for special diets</td>
      <td>228</td>
      <td>0.07</td>
      <td>0.00</td>
      <td>0.01</td>
      <td>7.64</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U72457&amp;numIds=0904010Z0BJABAA&amp;denomIds=9.4.1&amp;selectedTab=summary" target="_blank">Mevalia low protein frollini biscuits : 5</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U72457&amp;numIds=0904010Z0BJACAA&amp;denomIds=9.4.1&amp;selectedTab=summary" target="_blank">Mevalia low protein fruit bar : 6</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U72457&amp;numIds=0904010Z0BJADAP&amp;denomIds=9.4.1&amp;selectedTab=summary" target="_blank">Mevalia low protein cookies : 5</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U72457&amp;numIds=0601023AY&amp;denomIds=6.1.2&amp;selectedTab=summary">Empagliflozin/linagliptin</a><button type="button" data-toggle="collapse" data-target="#table_high_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>11</td>
      <td>Other antidiabetic drugs</td>
      <td>2412</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>7.46</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U72457&amp;numIds=0601023AYAAAAAA&amp;denomIds=6.1.2&amp;selectedTab=summary" target="_blank">Empagliflozin 10mg / Linagliptin 5mg tablets : 6</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U72457&amp;numIds=0601023AYBBABAB&amp;denomIds=6.1.2&amp;selectedTab=summary" target="_blank">Glyxambi 25mg/5mg tablets : 5</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U72457&amp;numIds=0411000F0&amp;denomIds=4.11&amp;selectedTab=summary">Galantamine</a><button type="button" data-toggle="collapse" data-target="#table_high_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>198</td>
      <td>Drugs for dementia</td>
      <td>579</td>
      <td>0.34</td>
      <td>0.03</td>
      <td>0.04</td>
      <td>7.29</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U72457&amp;numIds=0411000F0AAAFAF&amp;denomIds=4.11&amp;selectedTab=summary" target="_blank">Galantamine 16mg modified-release capsules : 58</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U72457&amp;numIds=0411000F0BIAAAE&amp;denomIds=4.11&amp;selectedTab=summary" target="_blank">Galzemic XL 8mg capsules : 5</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U72457&amp;numIds=0411000F0BIABAF&amp;denomIds=4.11&amp;selectedTab=summary" target="_blank">Galzemic XL 16mg capsules : 16</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U72457&amp;numIds=0411000F0BJAAAE&amp;denomIds=4.11&amp;selectedTab=summary" target="_blank">Luventa XL 8mg capsules : 4</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U72457&amp;numIds=0411000F0BJABAF&amp;denomIds=4.11&amp;selectedTab=summary" target="_blank">Luventa XL 16mg capsules : 79</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U72457&amp;numIds=0411000F0BKAAAE&amp;denomIds=4.11&amp;selectedTab=summary" target="_blank">Gazylan XL 8mg capsules : 5</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U72457&amp;numIds=0411000F0BKABAF&amp;denomIds=4.11&amp;selectedTab=summary" target="_blank">Gazylan XL 16mg capsules : 31</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U72457&amp;numIds=0601023AL&amp;denomIds=6.1.2&amp;selectedTab=summary">Dapagliflozin/metformin</a><button type="button" data-toggle="collapse" data-target="#table_high_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>105</td>
      <td>Other antidiabetic drugs</td>
      <td>2412</td>
      <td>0.04</td>
      <td>0.00</td>
      <td>0.01</td>
      <td>6.42</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_high_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U72457&amp;numIds=0601023ALAAABAB&amp;denomIds=6.1.2&amp;selectedTab=summary" target="_blank">Dapagliflozin 5mg / Metformin 1g tablets : 105</a></div></td></tr></tbody></table>

        <h2>Prescribing where Colte Partnership (Tmr) PCN is lower than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_low">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U72457&amp;numIds=1202030S0&amp;denomIds=12.2.3&amp;selectedTab=summary">Neomycin sulfate</a><button type="button" data-toggle="collapse" data-target="#table_low_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>37</td>
      <td>Nasal preparations for infection</td>
      <td>65</td>
      <td>0.57</td>
      <td>0.84</td>
      <td>0.07</td>
      <td>-3.89</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U72457&amp;numIds=1202030S0AAAAAA&amp;denomIds=12.2.3&amp;selectedTab=summary" target="_blank">Neomycin 0.5% / Chlorhexidine hydrochloride 0.1% cream : 22</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U72457&amp;numIds=1202030S0BBAAAA&amp;denomIds=12.2.3&amp;selectedTab=summary" target="_blank">Naseptin nasal cream : 15</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U72457&amp;numIds=0403040X0&amp;denomIds=4.3.4&amp;selectedTab=summary">Mirtazapine</a><button type="button" data-toggle="collapse" data-target="#table_low_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>1378</td>
      <td>Other antidepressant drugs</td>
      <td>3612</td>
      <td>0.38</td>
      <td>0.56</td>
      <td>0.07</td>
      <td>-2.56</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U72457&amp;numIds=0403040X0AAAAAA&amp;denomIds=4.3.4&amp;selectedTab=summary" target="_blank">Mirtazapine 30mg tablets : 382</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U72457&amp;numIds=0403040X0AAAJAJ&amp;denomIds=4.3.4&amp;selectedTab=summary" target="_blank">Mirtazapine 30mg orodispersible tablets : 23</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U72457&amp;numIds=0403040X0AAALAL&amp;denomIds=4.3.4&amp;selectedTab=summary" target="_blank">Mirtazapine 15mg orodispersible tablets : 81</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U72457&amp;numIds=0403040X0AAAMAM&amp;denomIds=4.3.4&amp;selectedTab=summary" target="_blank">Mirtazapine 45mg orodispersible tablets : 18</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U72457&amp;numIds=0403040X0AAANAN&amp;denomIds=4.3.4&amp;selectedTab=summary" target="_blank">Mirtazapine 15mg tablets : 539</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U72457&amp;numIds=0403040X0AAAPAP&amp;denomIds=4.3.4&amp;selectedTab=summary" target="_blank">Mirtazapine 45mg tablets : 335</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U72457&amp;numIds=1302020E0&amp;denomIds=13.2.2&amp;selectedTab=summary">Zinc oxide</a><button type="button" data-toggle="collapse" data-target="#table_low_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>0</td>
      <td>Barrier preparations</td>
      <td>25</td>
      <td>0.00</td>
      <td>0.51</td>
      <td>0.24</td>
      <td>-2.16</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U72457&amp;numIds=0406000F0&amp;denomIds=4.6&amp;selectedTab=summary">Cyclizine hydrochloride</a><button type="button" data-toggle="collapse" data-target="#table_low_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>74</td>
      <td>Drugs used in nausea and vertigo</td>
      <td>975</td>
      <td>0.08</td>
      <td>0.17</td>
      <td>0.04</td>
      <td>-2.09</td>
      <td><img class="zoom" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAPwAAABICAYAAADS8JgEAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAALEgAACxIB0t1+/AAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjMsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+AADFEAAAH+0lEQVR4nO2df4ycRRnHP1OOIjTYAkKoUBwxVpT6q60QOH9V7w/JXBQREkgEUtECQrHoHx0wiJg0zIkKorHYSBNKMVEiUeyACUgF0qT8aBMt2gCNDqBAqhQIWiktff1j5uh6XAt3++7O7L7PJ5ns7W2y873Z+868O8/zPqOqqkIQhGYwJbcAQRC6hxheEBqEGF4QGoQYXhAahBheEBqEGF4QGoQYXhAahBheEBqEGF4QGoQYXhAaRD2GV0rycwWhBxjILaAktPVTgOOBjwHzgZnAEcSJcRfwEvA08I+WtgV4NDjzcg7NgjARVC03zyhVUVWq/TfKg7b+MOBLwFeAZ4H7gAeAvwNbiWYfAKYDbweOSu1o4N3AbGAnsBn4M7AeWBec+WdX/xBBeAMabXht/VRgCfBVYDWwIjjz5CTfazpwHDAHOAkYJF4ZrAPuBXxw5l916BaEydJYw2vrTwRWAn8ArgjObOtAH28DTgaGgGHgKeAW4BfBmRfr7k8Q3ojGGV5br4CvA4uAc4IzD3Sx33nA2cDngbXAD4MzG7vRvyBAwwyvrT8IuDk9PS8480ImHVOBM4CvAf8FrgLWBmck2iF0lMYYXlt/JPAb4E7gqhLMlVb9TxANXwFXBmfuzatK6GcaYXht/Wzgt8Cy4Myq3HrGkoy/gGj8ncQ9hXV5VQn9SN8bXls/D7gVOD84c1duPfsiGX8IWEYMD14enHkkryqhn+hrw2vrFwA3AmcGZx7MrefNkoz/BeA7wEPAt4IzT+RVJfQDfWt4bf1pwAjw2eDM5tx6JoO2fgBYCFwG3E78SiLJPMKk6UvDa+vPBxYDpwRnnsqtp11SdGExMUFoFfCj4MzWvKqEXqSvDJ9y4a8mZrmd2m+Zbdr6Q4CLgS8DdwDfD85syatK6CX6xvDa+gOJq98uYGE/38yS/tZzgEuBR4DriLn72UONQtn0heG19UcQY+z3EENau3Np6Sba+v2AzwEXAYcDy4HVwZmXsgoTiqXnDa+tnwP8ChgJzqzMoaEEtPXvBS4gpu2uAZYHZzblVSWURk8bXlt/LnAlMU12bbf7LxFt/TTgLOBCYDvwE+C24MyOrMKEIuhJw6dd6x8DxwJnBWee6VbfvUKK5Z9A3Nn/JHF/47rgzHM5dQl56TnDa+vfA/ySmCr77eDMrm7028ukAh8XAecRbx76QSduBxbKp2cMn1ashcAVwIXBmd91sr9+RFs/A7iEaPxVROM/n1eV0E16wvDa+sOBFcABxO/rcgnfBsn4S4gT6HLg+uDM9ryqhG5QvOG19cPA9cA1wA0Sa66PVJHnMuLO/neBG4MzO/OqEjpJsYbX1h8MfA/4MHB2cObROt9f2IO2/hhitGMwPd7alFyGplGk4bX1Q8Rw0mrgall1ukOK5S8D3kE0/h1i/P6iKMOnVf0a4CPE9Ng/ta1NmDCpwOc3gXcC1xKLbv4nryqhDooxfMuqfjPgZFXPj7b+fcRdfQN44OfEnP1XswoTJk12w8uqXj4pe++M1N5PvGfh/tQel43U3iGb4VNc/XTi7aw3Iat6T6Ctfyux/t4g8UiuWcCDxNN2NgAbJbZfLlkMr63/ADHUth1YEpx5rH0RQg5SmvMJxCu0+cDc9NKG1B4mTgJy8EYBdNXw2vpDiXXahoBvBGd8+50LpZEKdcwlHrwxOgnsJtbnuwe4W2r05aErhk+53JcST11ZDlwrd281izTZnwh8OrVpxNN37iYewtFX1YlKpaOGT7u8i4m7vD8jpnBmOe1FKIuULr2AaP5PAf8Gfk+cAO6XMGBnqN3wKV3zdOCLwMHE21hvkVxtYV9o6zXR/EPAR4G/smcCeEg2dOuhbcNr6wfCyPBOvXSNJZ6QehRwGzFL7o8SshEmSipGOoc9l/9zgceJewCj7W/yvzVxJmT49EEcS/wARtucMDI8Uy9dczkxOWOTfBBCnaTafccRIwGjEYGjgSeBx1raE8DTwLPBmVfyqC2biRr+GSAAG1PbAPwljAzvyF21VmgWaRKYBcxuaccAM4Ejgf2B54BtwAvAi+M8bgd2pPbyXn4eba+kx129vKBN1PD7jZtWWUCZakFoJV2NHgYcAkwHZozTDiTWWDgAeEvLz2OfT2153H9MV7v5/wlhvMeJtlFTtppz7O9UagRnfvpmx6WeTbsaUUotqqpqRW4d41GyNihbX8naoGx9dWqbUseb1Myi3AL2QcnaoGx9JWuDsvXVpq1EwwuC0CHE8ILQIEo0fJHfoxIla4Oy9ZWsDcrWV5u24jbtBEHoHCWu8IIgdIiBnJ0rpT4OnAxsrapqpVLqVOAzVVVdMPa1wrQtIU6W91VV9XC3te1F37nA8cCdwKuUNXat2j5IeWN3CrE68iZiQk5JY9eq7V20OXa5V/iTqqpyxKOOqarq18RMvte9Vpi2bcQkjJwT5lh9NwE3EFOfSxu7Vm3FjR2xWs8sYoZdUWM3RlvbY5fb8PvaQMi9ubDX/quqWpU+lKEu6nmdjNYnSqlp7DlCqqixa9VW4thVVfU8cDFxQipq7Fq11TF2WS/pgfVKqaXANqXUPOAgYFApNdjy2tYCtc0gVnLZkknbePouSXrmU97YvaZNKXUo5Y3dh4iXy+uBzYWN3WvalFKGNsdOdukFoUHkvqQXBKGLiOEFoUGI4QWhQYjhBaFBiOEFoUGI4QWhQYjhBaFBiOEFoUGI4QWhQYjhBaFBiOEFoUH8D7ZyyBcUp5LRAAAAAElFTkSuQmCC"></td>
    </tr>
    <tr id="table_low_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U72457&amp;numIds=0406000F0AAACAC&amp;denomIds=4.6&amp;selectedTab=summary" target="_blank">Cyclizine 50mg tablets : 74</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U72457&amp;numIds=0304010G0&amp;denomIds=3.4.1&amp;selectedTab=summary">Chlorphenamine maleate</a><button type="button" data-toggle="collapse" data-target="#table_low_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>53</td>
      <td>Antihistamines</td>
      <td>2777</td>
      <td>0.02</td>
      <td>0.06</td>
      <td>0.02</td>
      <td>-1.97</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_low_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U72457&amp;numIds=0304010G0AAABAB&amp;denomIds=3.4.1&amp;selectedTab=summary" target="_blank">Chlorphenamine 2mg/5ml oral solution : 10</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U72457&amp;numIds=0304010G0AAACAC&amp;denomIds=3.4.1&amp;selectedTab=summary" target="_blank">Chlorphenamine 4mg tablets : 22</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U72457&amp;numIds=0304010G0AAAPAP&amp;denomIds=3.4.1&amp;selectedTab=summary" target="_blank">Chlorphenamine 2mg/5ml oral solution sugar free : 12</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U72457&amp;numIds=0304010G0BCAAAC&amp;denomIds=3.4.1&amp;selectedTab=summary" target="_blank">Piriton 4mg tablets : 8</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U72457&amp;numIds=0304010G0BCACAB&amp;denomIds=3.4.1&amp;selectedTab=summary" target="_blank">Piriton 2mg/5ml syrup : 1</a></div></td></tr></tbody></table>

    </div>
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.11.3/jquery.min.js"></script>
    <script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.5/js/bootstrap.min.js"></script>
</body>

</html>